April 7, 2021
JACKSONVILLE, Fla. – Johnson & Johnson Vision today announced a global strategic collaboration with contact lens manufacturer Menicon. As part of the collaboration, Menicon will develop and manufacture contact lenses to help manage the progression of myopia in children. Johnson & Johnson Vision will focus on expanding availability of these lenses around the world. The collaboration is part of a broader commitment from Johnson & Johnson Vision to bring forward a novel portfolio of products and services to manage the progression of myopia in children.
“For decades, Johnson & Johnson Vision has invested in research collaborations with academic centers, research institutes, and leading global health organizations who share our vision of leading with science to reshape the future of myopia and eye health,” said Johnson & Johnson Vision Care Global President Peter Menziuso. “Our collaboration with Menicon marks another step forward to bring a portfolio of differentiated products to help manage the progression of myopia in children, as we work toward our vision of helping the world see better, connect better, live better.”
The strategic collaboration with Menicon is the latest from Johnson & Johnson Vision to address the growing myopia epidemic following the development of a first-of-its-kind myopia management guide with new recommendations for eye care professionals, and the establishment of a novel research partnership with the Singapore National Eye Centre (SNEC) and the Singapore Eye Research Institute (SERI).
“As eye care practitioners, we see the long-term impact when myopia progresses or worsens, which can lead to other eye disease and even loss of vision,” said Professor Ian Flitcroft, MA, DPhil, FRCOphth. “There is no safe level of myopia, and there is an emerging need for more myopia treatment options, with an even greater need for industry, eye care providers, and parents to collaborate and help stop the progression of myopia in children.”